1203 related articles for article (PubMed ID: 28912116)
41. Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.
Ousmen A; Conroy T; Guillemin F; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Hamidou Z; Bonnetain F; Anota A
Health Qual Life Outcomes; 2016 Dec; 14(1):167. PubMed ID: 27914467
[TBL] [Abstract][Full Text] [Related]
42. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
43. Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
Shen MH; Chen LP; Ho TF; Shih YY; Huang CS; Chie WC; Huang CC
BMC Cancer; 2018 Apr; 18(1):353. PubMed ID: 29606101
[TBL] [Abstract][Full Text] [Related]
44. Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.
Ayana BA; Negash S; Yusuf L; Tigeneh W; Haile D
PLoS One; 2016; 11(6):e0157359. PubMed ID: 27304066
[TBL] [Abstract][Full Text] [Related]
45. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
[TBL] [Abstract][Full Text] [Related]
46. Reliability and Validity of the EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale) among Thai Women with Breast Cancer Undergoing Taxane-Based Chemotherapy.
Rattanakrong N; Thipprasopchock S; Siriphorn A; Boonyong S
Asian Pac J Cancer Prev; 2022 May; 23(5):1547-1553. PubMed ID: 35633537
[TBL] [Abstract][Full Text] [Related]
47. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
Davda J; Kibet H; Achieng E; Atundo L; Komen T
J Patient Rep Outcomes; 2021 Jan; 5(1):4. PubMed ID: 33415528
[TBL] [Abstract][Full Text] [Related]
48. Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23.
Jayasekara H; Rajapaksa LC; Brandberg Y
Qual Life Res; 2008 Aug; 17(6):927-32. PubMed ID: 18500576
[TBL] [Abstract][Full Text] [Related]
49. Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.
Paradowski J; Tomaszewski KA; Bereza K; Tomaszewska IM; Pasternak A; Paradowska D; Szczęsny E; Golec EB; Greimel ER; Bottomley A
Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):157-63. PubMed ID: 24354727
[TBL] [Abstract][Full Text] [Related]
50. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
[TBL] [Abstract][Full Text] [Related]
51. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
Zhang L; Su YJ; Chen JY; Liao ZC; Luo ZQ; Xie SM; Zhang J; Lin YS; Guo H; Sun WL; Pekbay B; Miller AR; Luo L; Rui YH; Li MH; Wang CL
Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
[TBL] [Abstract][Full Text] [Related]
52. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer.
Goo AJ; Shin DW; Yang HK; Park JH; Kim SY; Shin JY; Kim YA; Kim C; Hong NS; Min YJ; Park K
J Geriatr Oncol; 2017 Jul; 8(4):271-276. PubMed ID: 28377101
[TBL] [Abstract][Full Text] [Related]
53. Quality of life in breast cancer patients with bisphosphonate-related osteonecrosis of the jaws and patients with head and neck cancer: a comparative study using the EORTC QLQ-C30 and QLQ-HN35 questionnaires.
Kyrgidis A; Triaridis S; Kontos K; Patrikidou A; Andreadis C; Constantinidis J; Vahtsevanos K; Antoniades K
Anticancer Res; 2012 Aug; 32(8):3527-34. PubMed ID: 22843941
[TBL] [Abstract][Full Text] [Related]
54. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Sibhat SG; Fenta TG; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
[TBL] [Abstract][Full Text] [Related]
55. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
[TBL] [Abstract][Full Text] [Related]
56. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
57. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
58. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer.
Michels FA; Latorre Mdo R; Maciel Mdo S
Rev Bras Epidemiol; 2013 Jun; 16(2):352-63. PubMed ID: 24142007
[TBL] [Abstract][Full Text] [Related]
59. Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer.
Paradowska D; Tomaszewski KA; Bałajewicz-Nowak M; Bereza K; Tomaszewska IM; Paradowski J; Pityński K; Skotnicki P; Greimel ER; Bottomley A
Eur J Cancer Care (Engl); 2014 Mar; 23(2):214-20. PubMed ID: 23957381
[TBL] [Abstract][Full Text] [Related]
60. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
